Skip Navigation LinksHome > March 29, 2002 - Volume 16 - Issue 5 > Accumulation of DC-SIGN+CD40+ dendritic cells with reduced C...
AIDS:
Basic Science

Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection

Loré, Karina,b,*; Sönnerborg, Andersa,b; Broström, Christinab; Goh, Li-Eanc; Perrin, Lucd; McDade, Hughc; Stellbrink, Hans-Jürgene; Gazzard, Brianf; Weber, Rainerg; Napolitano, Laura A.h; van Kooyk, Yvettei; Andersson, Janb

Free Access
Article Outline
Collapse Box

Author Information

From the aDivision of Clinical Virology, Department of Microbiology, Pathology and Immunology and the bCenter for Infectious Medicine of the Department of Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden, the cHIV Department, GlaxoWellcome R&D, Middlesex, UK, the dDepartment of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland, eMed. Poliklinik, Universitatsklinikum Eppendorf, Hamburg, Germany, fSt Stephen's Clinic, Chelsea & Westminster Hospital, London, UK, the gDepartment of Clinical Immunology, Royal Free Hospital, London, UK, the hGladstone Institute of Virology and Immunology, University of San Francisco, San Francisco, California, USA and the iDepartment of Molecular Cell Biology, Free University Medical Center Amsterdam, Amsterdam, the Netherlands. *Present address, National Institutes of Health, Vaccine Research Center, Bethesda, Maryland, USA.

Requests for reprints to: Dr K. Loré, National Institutes of Health, Vaccine Research Center, Bldg 40 Room 3612B, 40 Convent Drive, Bethesda, Maryland, USA. E-mail: klore@mail.nih.gov

Received: 18 July 2001;

revised: 19 October 2001; accepted: 1 November 2001.

Sponsorship: this work was supported by Glaxo Wellcome UK, the UCSF Center for AIDS Research (P30 MH59037), NIH grant CA66529 and A141536, the Swedish Physicians against AIDS research fund and the Swedish Medical Research Foundation grant 10850.

Collapse Box

Abstract

Background: Dendritic cells (DC) are target cells for HIV-1 and play a key role in antigen presentation and activation of T cells.

Objective: To characterize interdigitating DC in lymphoid tissue (LT) with regard to maturation, expression of cytokines and co-stimulatory molecules in HIV-1-positive patients.

Methods: DC were characterized by immunohistochemistry and in situ imaging in LT from patients with acute HIV-1 infection (aHI), antiretroviral treated patients, long-term non-progressors/slow progressors with HIV-1 infection (LTNP/SLP), patients with AIDS, HIV-1-negative controls and patients with acute Epstein–Barr virus (EBV) infection.

Results: A significant increase of interdigitating DC expressing CD1a, S-100b, CD83 and DC-SIGN was found in LT from patients with aHI (P < 0.02). The co-stimulatory molecules CD80 and CD86 were, however, only partially upregulated and the complete parafollicular network found in acute EBV infection was not generated, despite increased expression of interleukins 1α, 1β, 12; interleukin 1α receptor antagonist; interferon α; and CD40 expression. LTNP/SLP and treated aviremic subjects had increased frequency of interdigitating DC, albeit lower than in aHI, and low expression of CD80 and CD86. In contrast, patients with AIDS had fewer DC and reduced cytokine expression in LT.

Conclusions: In the early phase of HIV-1 infection, there was a migration of DC to LT comparable to that found in acute EBV infection. The infiltration of DC in LT in acute EBV infection was accompanied by upregulation of CD80 and CD86 expression, which did not occur in aHI. This co-stimulatory defect in aHI may have an impact on the development of HIV-1-specific T cell immunity.

Back to Top | Article Outline

Introduction

In vivo, immature dendritic cells (DC) engulf microbes and antigens in the periphery for subsequent intracellular processing into short peptides to be presented on MHC class I and II molecules. Such activated DC migrate to regional lymphoid compartments where they form a network as mature interdigitating DC enabling potent primary activation of naive T cells [1]. Antigen presentation by the mature DC also requires expression of co-stimulatory molecules, including CD40, CD80 and CD86, plus several cytokines in order to allow optimal expansion of antigen-specific T cells.

DC in the mucosa are the primary target cells for HIV-1 after sexual transmission [2]. Capture of HIV-1 is mediated by several receptors expressed on DC including CD4, CCR5 and CXCR4 [3] and the unique DC-SIGN molecule, which binds the HIV-1 envelope protein gp120 [4]. This latter interaction may result in a temporary uptake of receptor-coupled HIV-1 by DC without degradation of the virus and thus allows HIV-1 to be re-expressed on the cell surface.

Consequently, DC have a pivotal role in the pathogenesis of HIV-1 infection through delivery of the virus to lymphoid sites and transmission to neighboring CD4 T cells [5]. Also, DC expressing defects in their antigen-presenting capacity may lead to defective HIV-1-specific CD4 T cell activation [6,7].

The aims of the current study were to characterize the recruitment of interdigitating DC in vivo to lymphoid tissue (LT) during different stages of HIV-1 infection. The phenotypic features of DC required for efficient antigen presentation were also studied.

Back to Top | Article Outline

Methods

Patients and controls

LT biopsies [lymph nodes (LN) and tonsils] were collected from four cohorts of HIV-1-infected patients. The patients with acute HIV-1 infection (aHI) were enrolled in the international Quest/Probe3005 study [8]. Untreated patients with slow progressive HIV-1 infection (SLP) or long-term non-progessors (LTNP) [9], aviremic patients on potent antiretroviral treatment, control HIV-1-seronegative healthy individuals and patients with acute Epstein–Barr virus (EBV) infection were recruited from Huddinge University hospital, Stockholm, Sweden. Patients with AIDS came from San Francisco General Hospital at the University of California, San Francisco. Approvals were obtained from the institutional review boards and ethical committees at each participating site. Previous studies have shown no difference in cell distribution in the parafollicular areas of the LT nor in the frequency of cytokine or co-stimulatory expressing cells between LN and tonsilar tissue [10–12]. Furthermore, earlier studies did not find any difference in LT with age using specimens obtained from individuals between 5 and 60 years of age, which justified the use of seronegative control material from younger patients than the HIV-1- infected cohort [10,11,13].

Back to Top | Article Outline
CD4 T cell and viral load estimates

CD4 T cell counts in peripheral blood were determined by routine flow cytometric analysis. Plasma viral loads were determined with the Amplicor HIV Monitor test (Roche Molecular Systems, Sommerville, New Jersey, USA) with a detection limit of < 50 copies/ml. Cell-associated HIV-1 RNA and DNA were measured on cells obtained from LT and peripheral blood mononuclear cells (PBMC) using the reagents of the Amplicor HIV-1 Monitor assay (Roche) [14]. Cell-associated HIV-1 DNA was measured by incubating the nucleic acid preparation with Rnase A Dnase-free (Sigma, Buchs, Switzerland). One million cells from each sample were analyzed. The cut-off values were approximately 3 RNA copies/106 cells and 5 DNA copies/106 cells. The mean coefficient of variation for 1000–10 copies/106 cells was 12% (range, 3–26) for cell-associated RNA and 18% (range, 2–29) for cell-associated DNA.

Back to Top | Article Outline
Detection of cytokines and cellular markers by immunohistochemistry

The staining procedure used on cryopreserved LT to identify cytokines and cell surface markers at the single cell level has previously been described [15]. The staining reactions were developed brown using diaminobenzidine tetrahydrochloride (DAB). Anti-CD8 (SK1, Becton Dickinson, San Jose, California, USA) was the CD8 T cell subset-specific antibody. The DC phenotypic antibodies were anti-CD1a (NA 1/34, Dako, Glostrup, Denmark), anti-S-100 β-subunit (S-2532, Sigma, St Louis, Missouri, USA), anti-CD83 (HB15e, PharMingen, San Diego, California, USA), anti-DC-LAMP (provided by Dr S. Lebecq [16]) and anti-DC-SIGN (provided by Dr Y. van Kooyk, [4]). The antibodies against co-stimulatory molecules were anti-CD40 (S2C6, Mabtech, Nacka, Sweden), anti-CD80 (anti-CD80, BB1, PharMingen, and anti-BB-1, L307.4, Camfolio, Becton Dickinson) and anti-CD86 (IT2.2, PharMingen). The cytokine-specific antibodies and the secondary antibodies were previously described [15].

Back to Top | Article Outline
Quantification of cytokines and phenotype of cells by in situ image analysis

Digital images of stained samples were transferred into a DMR-X microscope (Leica, Wetzlar, Germany) and further into a computerized image analysis system (Quantimet 550IW, Leica, Cambridge, UK). The complete LT sections were assessed in each sample in a semiquantitative way by a specialized software program [15,17]. The presence of cells expressing DC-specific antigens, CD40 and CD8 was evaluated as the percentage positive stained cellular area out of the total hematoxylin stained cellular area, which was 3–7 × 105/μm2 representing approximately 0.4–1.1 × 104 cells. Furthermore, the numbers of cytokine-, CD80- and CD86-expressing cells were estimated by counting the positive cells in each digital image manually. The number of positive cells out of the total number of cells was calculated and presented as expressing cells per 10 000 cells. All of the analyses were performed in a blinded fashion. These evaluation methods have an interassay variability of < 10% [17,18].

Back to Top | Article Outline
Two-colour staining for co-localization

The staining experiments with immunofluorescence were carried out in blocking serum BSA-C (Aurion BSA-C, Wagningen, the Netherlands). The immunoglobulin-specific secondary biotinylated antibodies [15] were used together with Alexa 488- or Alexa 546-labeled streptavidin (Molecular Probes Inc., Eugene, Origon, USA) and an avidin–biotin blocking kit (Vector Laboratories, Burlingame, California, USA). The sections were evaluated in a laser scanning confocal microscope (SP102, Leica). Cells stained with two colours were counted manually in a blinded fashion.

Back to Top | Article Outline
Statistical analysis

Statistical significance was assessed by the Mann–Whitney U-test and considered significant at two-tailed P value < 0.05.

Back to Top | Article Outline

Results

Increase of interdigitating dendritic cells in the acute phase of HIV-1 infection

Interdigitating DC are mainly found in the parafollicular T cell-rich areas of LT [1]. DC represent a heterogeneous cell lineage with several phenotypic and functional subsets of cells, not all of which have been fully elucidated [19]. Several antigens expressed on DC were, therefore, used to assess their phenotype and maturation [20]. Interdigitating DC characterized by CD1a, S-100b, CD83, DC-LAMP and DC-SIGN expression had similar localization in LT derived from tonsils or LN (Fig. 1). Furthermore, DC expressing CD1a, S-100b and DC-SIGN and, to lesser extent, more mature DC expressing CD83 and DC-LAMP were also localized in the epithelial layer and crypts in tonsils. However, in order to standardize the assessments, DC localized in the epithelial regions were not included in the assessments.

Fig. 1
Fig. 1
Image Tools

The LT from the patients with aHI was characterized by a significantly, up to tenfold, increased frequency of DC expressing CD1a, S-100b, CD83 and DC-SIGN compared with HIV-1-seronegative healthy controls (P < 0.02) (Fig. 2). Fewer cells expressed DC-LAMP. The LT from these patients also showed 6- and 25-fold higher intracellular HIV-1 DNA and HIV-1 RNA loads, respectively, compared with that in PBMC (P < 0.01) (Table 1). In addition, a similar pattern of accumulation of mature DC in LT was seen in the patients with acute EBV infection. The frequency of interdigitating DC in LTNP/SLP was lower than in the patients with aHI or EBV infection but still elevated compared with HIV-seronegative individuals (P < 0.04, for CD1a and CD83DC). A small increase in the frequency of DC was also noticed in the patients successfully treated with antiretroviral drugs, with the exception of S-100b DC, which persisted in elevated numbers (P < 0.03). In contrast, the total frequency of DC was reduced in LT from the patients with AIDS compared with the other HIV-1-infected cohorts. However, the total cellularity in the LT from the patients with AIDS was also severely depleted, resulting in a relative increase in the percentage of S-100b-expressing area compared with LT from seronegative controls (P < 0.02).

Fig. 2
Fig. 2
Image Tools
Table 1
Table 1
Image Tools
Back to Top | Article Outline
Dissociation between CD40 and CD80/86 expression

The typical pattern of CD40 expression consisted of a weak staining in the follicles (CD40lowcells, presumably B cells) and bright staining in the parafollicular areas (CD40highcells), as reported earlier [21] (Fig. 3d). Higher intensity values for CD40 staining measured by computerized imaging were obtained in parafollicular areas than in follicular areas. Double labeling showed that the bright CD40high expression was to a great extent (> 80%) co-localized with CD1a DC in the parafollicular areas. A significantly increased frequency of CD40high cells was evident in patients with aHI and in patients with acute EBV infection compared with that in healthy controls (P < 0.03) (Fig. 3g). The healthy controls, the LTNP/SLP and the treated aviremic cohort showed comparable levels (P = 0.06). Patients with AIDS showed a significantly reduced expression of CD40high in the LT (P < 0.02).

Fig. 3
Fig. 3
Image Tools

The majority (> 60%) of bright CD80 and CD86 cells were also found to be co-localized with CD1a DC in the parafollicular areas in HIV-1 infection, EBV infection and seronegative healthy tissue (Fig. 3a). LT from patients with aHI showed upregulation of the number of both CD80 and CD86 cells compared with uninfected healthy controls (Fig. 3e,f) (P < 0.02). However, patients with acute EBV infection showed significantly higher numbers of CD80 and CD86 DC in the parafollicular area compared with patients with aHI (P < 0.01). In acute EBV infection, CD80 and CD86 cells generated a complete network (Fig. 3c), which co-localized with DC expression of CD1a, S-100b, DC-LAMP and DC-SIGN. This was in contrast to the patients with aHI, in whom no intact network for CD80 and CD86 was seen. CD80 and CD86 expression was found in scattered clusters of cells in LT from HIV-1-infected individuals (Fig. 3b). The CD80 and CD86 cells were not significantly increased in the LT from LTNP/SLP, patients with AIDS or in aviremic treated patients compared with seronegative controls, again leading to an incomplete network of CD80 and CD86 expression compared with that in acute EBV infection (Fig. 3e,f). No difference in distribution or frequencies of CD40, CD80 and CD86 cells was found to correlate with the age of the patients or the type of biopsy donated.

Back to Top | Article Outline
Increased CD8 expression

An increased frequency of CD8 T cells in LT was observed in the patients with aHI, in LTNP/SLP and in treated chronically infected asymptomatic HIV-1 patients compared with the controls (Fig. 3h) (P < 0.02). In contrast, the patients with AIDS had a severe depletion in the absolute number of cells, resulting in low total levels of CD8 T cells.

Back to Top | Article Outline
Expression of cytokines

Interleukin 1 receptor antagonist (IL-1ra) was mainly expressed in CD1aDC localized in the crypts or in epithelial layer of the tonsils. However, the number of IL-1ra-expressing cells within the LT was also found to be upregulated in the aHI cohort, but not other cohorts, compared with the healthy controls (P < 0.01) (Table 2). Interleukin (IL) 1α was predominantly expressed in endothelial cells in high endothelial venules. Approximately 10% of all IL-1α-expressing cells were CD1aDC in the parafollicular area. The total number of IL-1α-expressing cells, compared with healthy controls, was increased during aHI (P < 0.01) and in LTNP/SLP (P < 0.02), but not in those with AIDS or those treated with antiretroviral drugs. IL-1β was expressed mainly in the parafollicular areas. CD1a DC represented a portion (roughly estimated 20–50%) of the total number of IL-1β-expressing cells. The patients with aHI showed a significant rise in IL-1β-expressing cells compared with healthy controls (P < 0.01), which was not observed in the other HIV-1-infected cohorts. In contrast, expression of tumor necrosis factor α was not significantly upregulated in any of the HIV-1 cohorts.

Table 2
Table 2
Image Tools

Furthermore, the vast majority of the HIV-1-infected individuals had cells expressing interferon α (IFN-α) in their LT while IFN-α was only found in one of the four HIV-1-seronegative controls. The highest number of IFN-α-expressing cells was found in the patients with aHI, but the LTNP/SLP group also had a significant upregulation of IFN-α (P < 0.03). In addition, the aHI cohort had increase expression of IL-12 p70 (P < 0.02), which was not found in the other HIV-1 cohorts. No difference in the numbers of cytokine-expressing cells was found between LN and tonsil tissue.

Back to Top | Article Outline

Discussion

Here, we provide evidence that there is a significant migration in vivo of DC to the lymphoid compartments in the early phase of HIV-1 infection to an extent that is comparable to that found in acute EBV infection. However, patients with aHI show a distinct block in co-stimulatory molecule expression by DC, as indicated by a significant induction of CD40 but, to lesser extent, CD80 and CD86. This suggests that functional defects of DC may occur at the very early onset of HIV-1 infection and are likely to persist in the asymptomatic chronic phase of the infection. In addition, DC binding of HIV-1 through CD4, CCR5, CXCR4 or the DC-SIGN receptor can promote transmission of HIV-1 to CD4 T cells [3,4]. Therefore, the massive migration we found of DC-SIGN DC to the LT shortly after HIV-1 transmission may be followed by a subsequent local activation of CD4 T cells, which would facilitate HIV-1 infection and replication in the latter cells [5,22]. Indeed, the intracellular HIV-1 DNA as well RNA levels were significantly higher in cells in the LT compared with PBMC in the acutely infected patients. This activation may contribute to the peak plasma viremia noticed during the initial phase in aHI [23].

The frequencies of immature DC in blood [6,24], skin [6] and mucosa [25] are reduced during HIV-1 infection. Our contrasting finding of an increase of interdigitating DC in LT suggests that there is a redistribution of DC from the periphery to the LT during HIV-1 infection. Several factors, such as persistent production of HIV-1 antigens or continuous proinflammatory cytokine and chemokine expression in LT, may be involved in this recruitment. Furthermore, persistent increased frequency of DC in LT could also reflect reduced elimination of DC by CD8 T cells and natural killer cells [26].

LTNP/SLP is a highly selected group representing a small proportion of HIV-1 patients who have preserved CD4 T cell levels and low viral replication [9]. Our finding of an increase in interdigitating CD1a DC and CD83 DC and CD8 T cells also in these patients indicates that this condition is associated with a persistent activation of cellular immunity. Patients on successful antiretroviral treatment had lower incidences of DC and CD8 T cells in the LT than patients with aHI and LTNP/SLP, which may indicate that pharmacologically suppression of virus production reduces the recruitment and need of DC and CD8 T cells. The fall in the levels of both DC and CD8 T cells in the group with AIDS compared with the other HIV-1-infected cohorts probably reflects the failure of the regenerative capacity of the immune system.

The maturation process of DC is complex [18]. This was exemplified in the current study by the high frequency of CD1a, S-100b, CD83, DC-SIGNDC without a concomitant increase of DC LAMP expression, a molecule upregulated late in the DC maturation process. In addition, CD40, required for CD40 ligand-mediated DC activation and maturation, was upregulated during the acute stage of both HIV-1 and EBV infection. However, CD80 and CD86 expression occurred only in scattered clustered DC in HIV-1 infection, in contrast to acute EBV infection where their expression was found on higher numbers of cells forming a complete parafollicular network. Consequently, the interdigitating DC in HIV-1 infection may have insufficient CD80 and CD86 expression for the proliferative induction of efficient numbers of naive CD4 T cells in antigen-specific responses. Activation of naive T cells requires both T cell receptor binding to the specific peptide antigen–MHC complex on antigen-presenting cells and ligation of CD80/CD86 and CD28/CTLA-4 on the T cell surface. Studies in knock-out mice have shown that CD80 and CD86 ligation is required for CD4 T cell proliferation upon antigen stimulation [27,28]. Downregulated expression of CD80 and CD86 on monocytes from HIV-1-infected individuals has previously been reported, which has been shown to lead to subsequent impaired activation of CD8 T cells, resulting in inefficient suppression of HIV-1 replication [29–31]. Binding of HIV-1 gp120 to CD4 T cells inhibits upregulation of CD80 on co-cultured antigen-presenting cells [32]. HIV-1 may, therefore, interfere with the regulation of co-stimulatory molecules, which would contribute to defects in the activation of HIV-1-specific T cell clone expansion. The ratio between intracellular HIV-1 RNA levels in LT and PBMC was 25:1 in the aHI patients, indicating much higher production of gp120 in LT where the downregulation of CD80/CD86 expression was found. The functional capacity of the DC-mediated HIV-1-specific T cell response in the patients enrolled in the current study has not been investigated. However, there are data indicating that in vitro cultured blood-derived DC exposed to HIV-1 do not upregulate CD80/CD86 and are unable to induce proliferation of T cells [7,33], although immature blood-derived DC may not completely mimic the interdigitating mature DC in LT.

Another important aspect to consider is that HIV-1 harboring mature CD80/CD86 DC promote virus transmission and replication in clustered CD4 T cells both in vitro and in vivo [5,34]. HIV-1 particles expressing CD80 and CD86 in the viral envelope, derived from the host cells, mediate intracellular signaling cascades that upregulate HIV-1 replication in infected CD4 T cells [35]. Furthermore, the transmission of HIV-1 from DC to CD4 T cells can be inhibited by anti-CD80 or anti-CTLA-4 antibodies [36]. Restricted upregulation of these accessory molecules may, therefore, play a role in the host's prevention of DC-mediated spread of the virus to adjacent T cells.

The cytokine production profile of DC changes with the differentiation pathway [37]. Here, we could demonstrate differences in the cytokine expression pattern in DC depending on the maturity and the locality of the DC in the tissue. Intraepithelial immature CD1a DC expressed IL-1ra, while mature CD1a DC in the parafollicular areas of the LT expressed IL-1β and IL-1α. In addition, there were elevated numbers of cells expressing IL-12 and IFN-α in the parafollicular area in LT from aHI patients. We have previously found that cultured immature DC constitutively expressed IL-1ra and needed stimulation to induce production of other cytokines such as IL-1β, tumor necrosis factor α and IL-12 [33]. The mature DC accumulated in LT during HIV-1 infection found in the current study appeared to be functional in their ability to produce the cytokines inducing T helper type 1 responses. However, high expression of proinflammatory cytokines in DC may also induce HIV-1 replication in CD4 T cells [33].

In conclusion, accumulation of DC in LT was similar in aHI and acute EBV infection. A persistent small increase of interdigitating DC was also observed in LTNP/SLP. However, DC did not seem to undergo full differentiation in HIV-1 infection during the initial adaptive immune response, characterized by incomplete upregulation of the co-stimulatory molecules CD80 and CD86. The failure of DC to differentiate completely is likely a factor limiting their capacity to generate HIV-1-specific CD4 T cell responses. Consequently, lack of proper helper function may restrict CD8 T cell maturation and prevent effective elimination of HIV-1-infected cells. However, one may also argue that this downregulation is important to control the activation of T cells and thereby HIV-1 replication. Overall, reconstitution of CD80/CD86 expression in DC may be important to consider in development of therapeutic HIV-1 vaccines to be administrated in combination with effective antiretroviral therapy.

Back to Top | Article Outline

Acknowledgements

We would like to thank all the patients involved and the recruiting sites for enrolling patients in the Quest PROB 3005 study and Glaxo Wellcome UK for organizing the network. We are also grateful for the assistance of those who provided additional LT biopsies including Karin Ågren, Huddinge University Hospital, Nancy Abbey, Brian Herndier and Joseph M. McCune, San Francisco General Hospital, University of San Francisco, San Francisco. We also thank PharMingen, San Diego, California for kind supply of cell marker- and cytokine-specific antibodies and Dr S. Lebecq, Laboratory of Immunological Research, Dardilly for kindly providing the anti-DC-LAMP antibody.

Back to Top | Article Outline

References

1. Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev 1997, 156: 25–37.

2. Spira AI, Marx PA, Patterson BK. et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996, 183: 215–225.

3. Granelli-Piperno A, Moser B, Pope M. et al. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med 1996, 184: 2433–2438.

4. Geijtenbeek TB, Kwon DS, Torensma R. et al. DC-SIGN, a dendritic cell-specific HIV-1–binding protein that enhances trans-infection of T cells [see comments]. Cell 2000, 100: 587–597.

5. Pope M, Betjes MG, Romani N. et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994, 78: 389–398.

6. Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990, 71: 38–45.

7. Knight SC, Macatonia SE, Patterson S. Infection of dendritic cells with HIV1: virus load regulates stimulation and suppression of T-cell activity. Res Virol 1993, 144: 75–80.

8. Goh LE, McDade H, Kinloch S. et al. The quest trial, a paradigm of HIV collaborative research. Nat Med 2000, 6: 1194.1194.

9. Brostrom C, Visco-Comandini U, Yun Z, Sonnerborg A. Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors. J Infect Dis 1999, 179: 1542–1548.

10. Andersson J, Abrams J, Bjork L. et al. Concomitant in vivo production of 19 different cytokines in human tonsils. Immunology 1994, 83: 16–24.

11. Andersson J, Behbahani H, Lieberman J. et al. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS 1999, 13: 1295–1303.

12. Rebelatto MC, Mead C, HogenEsch H. Lymphocyte populations and adhesion molecule expression in bovine tonsils. Vet Immunol Immunopathol 2000, 73: 15–29.

13. Agren K, Andersson U, Litton M, Funa K, Nordlander B, Andersson J. The production of immunoregulatory cytokines is localized to the extrafollicular area of human tonsils. Acta Otolaryngol 1996, 116: 477–485.

14. Yerly S, Rutschmann OT, Opravil M, Marchal F, Hirschel B, Perrin L. Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study. J Infect Dis 1999, 180: 850–853.

15. Andersson U, Litton MJ, Fehniger T, Ulfgren A-K, Andersson J. Detection and quantification of cytokine-producing cells by immunostaining. In Molecular Probes for Cytokine and Gene Detection. Edited by B. Patterson. Boston, MA: Birkheusser; 2000: 55–79.

16. de Saint-Vis B, Vincent J, Vandenabeele S. et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 1998, 9: 325–336.

17. Bjork L, Fehniger TE, Andersson U, Andersson J. Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis. J Leukoc Biol 1996, 59: 287–295.

18. Raqib R, Lindberg AA, Wretlind B, Bardhan PK, Andersson U, Andersson J. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun 1995, 63: 289–296.

19. Caux C. Pathways of development of human dendritic cells. Eur J Dermatol 1998, 8: 375–384.

20. Bell D, Young JW, Banchereau J. Dendritic cells. Adv Immunol 1999, 72: 255–324.

21. Vyth-Dreese FA, Dellemijn TA, Majoor D, de Jong D. Localization in situ of the co-stimulatory molecules B7. 1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Eur J Immunol 1995, 25: 3023–3029.

22. Masurier C, Salomon B, Guettari N. et al. Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J Virol 1998, 72: 7822–7829.

23. Lindback S, Thorstensson R, Karlsson AC. et al. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 2000, 14: 2333–2339.

24. Grassi F, Hosmalin A, McIlroy D, Calvez V, Debre P, Autran B. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 1999, 13: 759–766.

25. Spinillo A, Tenti P, Zappatore R, de Seta F, Silini E, Guaschino S. Langerhans’ cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection. Gynecol Oncol 1993, 48: 210–213.

26. Wilson JL, Heffler LC, Charo J, Scheynius A, Bejarano MT, Ljunggren HG. Targeting of human dendritic cells by autologous NK cells. J Immunol 1999, 163: 6365–6370.

27. Mandelbrot DA, Oosterwegel MA, Shimizu K. et al. B7–dependent T-cell costimulation in mice lacking CD28 and CTLA4. J Clin Invest 2001, 107: 881–887.

28. Yamada A, Kishimoto K, Dong VM. et al. CD28–independent costimulation of T cells in alloimmune responses. J Immunol 2001, 167: 140–146.

29. Dudhane A, Conti B, Orlikowsky T. et al. Monocytes in HIV type 1–infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. AIDS Res Hum Retroviruses 1996, 12: 885–892.

30. Kumar A, Angel JB, Aucoin S. et al. Dysregulation of B7.2 (CD86) expression on monocytes of HIV-infected individuals is associated with altered production of IL-2. Clin Exp Immunol 1999, 117: 84–91.

31. Barker E, Bossart KN, Fujimura SH, Levy JA. The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication. Cell Immunol 1999, 196: 95–103.

32. Chirmule N, McCloskey TW, Hu R, Kalyanaraman VS, Pahwa S. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J Immunol 1995, 155: 917–924.

33. Lore K, Sonnerborg A, Olsson J. et al. HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation. AIDS 1999, 13: 2013–2021.

34. Weissman D, Li Y, Orenstein JM, Fauci AS. Both a precursor and a mature population of dendritic cells can bind HIV. However, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells. J Immunol 1995, 155: 4111–4117.

35. Bounou S, Dumais N, Tremblay MJ. Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7–2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J Biol Chem 2001, 276: 6359–6369.

36. Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, Clark EA. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1994, 1: 317–325.

37. de Saint-Vis B, Fugier-Vivier I, Massacrier C. et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998, 160: 1666–1667.

Cited By:

This article has been cited 78 time(s).

AIDS Research and Human Retroviruses
Plasmacytoid Dendritic Cell Number and Responses to Toll-Like Receptor 7 and 9 Agonists Vary in HIV Type 1-Infected Individuals in Relation to Clinical State
Kaushik, S; Teque, F; Patel, M; Fujimura, SH; Schmidt, B; Levy, JA
AIDS Research and Human Retroviruses, 29(3): 501-510.
10.1089/aid.2012.0200
CrossRef
Plos Pathogens
Binding of HIV-1 gp120 to DC-SIGN Promotes ASK-1-Dependent Activation-Induced Apoptosis of Human Dendritic Cells
Chen, YX; Hwang, SL; Chan, VSF; Chung, NPY; Wang, SR; Li, ZY; Ma, J; Lin, CW; Hsieh, YJ; Chang, KP; Kung, SS; Wu, YC; Chu, CW; Tai, HT; Gao, GF; Zheng, BJ; Yokoyama, KK; Austyn, JM; Lin, CLS
Plos Pathogens, 9(1): -.
ARTN e1003100
CrossRef
Virulence
A dendrite in every pie Myeloid dendritic cells in HIV and SIV infection
Wonderlich, ER; Barratt-Boyes, SM
Virulence, 3(7): 647-653.
10.4161/viru.22491
CrossRef
Immunology and Cell Biology
Role for plasmacytoid dendritic cells in anti-HIV innate immunity
Muller-Trutwin, M; Hosmalin, A
Immunology and Cell Biology, 83(5): 578-583.
10.1111/j.1440-1711.2005.01394.x
CrossRef
Immunity
Selected Toll-like Receptor Ligands and Viruses Promote Helper-Independent Cytotoxic T Cell Priming by Upregulating CD40L on Dendritic Cells
Johnson, S; Zhan, YF; Sutherland, RM; Mount, AM; Bedoui, S; Brady, JL; Carrington, EM; Brown, LE; Belz, GT; Heath, WR; Lew, AM
Immunity, 30(2): 218-227.
10.1016/j.immuni.2008.11.015
CrossRef
Journal of Immunology
PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention
Kaufmann, DE; Walker, BD
Journal of Immunology, 182(): 5891-5897.
10.4049/jimmunol.0803771
CrossRef
Blood
Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression
Nascimbeni, M; Perie, L; Chorro, L; Diocou, S; Kreitmann, L; Louis, S; Garderet, L; Fabiani, B; Berger, A; Schmitz, J; Marie, JP; Molina, TJ; Pacanowski, J; Viard, JP; Oksenhendler, E; Beq, S; Abehsira-Amar, O; Cheynier, R; Hosmalin, A
Blood, 113(): 6112-6119.
10.1182/blood-2008-07-170803
CrossRef
Nature Immunology
A division of labor: DC subsets and HIV receptor diversity
Kavanagh, DG; Bhardwaj, N
Nature Immunology, 3(): 891-893.
10.1038/ni1002-891
CrossRef
Clinical and Diagnostic Laboratory Immunology
Antigen-specific gene expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets
McLaren, PJ; Mayne, M; Rosser, S; Moffatt, T; Becker, KG; Plummer, FA; Fowke, KR
Clinical and Diagnostic Laboratory Immunology, 11(5): 977-982.
10.1128/CDLI.11.5.977-982.2004
CrossRef
Journal of Immunology
Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS
Brown, KN; Trichel, A; Barratt-Boyes, SM
Journal of Immunology, 178(): 6958-6967.

Journal of Immunology
Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection
Turnbull, EL; Wong, M; Wang, SY; Wei, XP; Jones, NA; Conrod, KE; Aldam, D; Turner, J; Pellegrino, P; Keele, BF; Williams, I; Shaw, GM; Borrow, P
Journal of Immunology, 182(): 7131-7145.
10.4049/jimmunol.0803658
CrossRef
Journal of Pediatric Hematology Oncology
Tumor necrosis factor, interleukin 11, and leukemia inhibitory factor produced by Langerhans cells in Langerhans cell histiocytosis
By, UA; Tani, E; Andersson, U; Henter, JI
Journal of Pediatric Hematology Oncology, 26(): 706-711.

Journal of Virology
Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-Cell activation: Implications for viral immune escape
Majumder, B; Janket, ML; Schafer, EA; Schaubert, K; Huang, XL; Kan-Mitchell, J; Rinaldo, CR; Ayyavoo, V
Journal of Virology, 79(): 7990-8003.
10.1128/JVI.79.13.7990-8003.2005
CrossRef
Immunologic Research
Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model
Barratt-Boyes, SM; Brown, KN; Melhem, N; Soloff, AC; Gleason, SM
Immunologic Research, 36(): 265-274.

Blood
Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition
Groot, F; van Capel, TMM; Kapsenberg, ML; Berkhout, B; de Jong, EC
Blood, 108(6): 1957-1964.
10.1182/blood-2006-03-010918
CrossRef
Journal of Immunology
Local and systemic effects of intranodally injected CpG-C immunostimulatory-oligodeoxyribonucleotides in macaques
Teleshova, N; Kenney, J; Van Nest, G; Marshall, J; Lifson, JD; Sivin, I; Dufour, J; Bohm, R; Gettie, A; Robbiani, M
Journal of Immunology, 177(): 8531-8541.

Nature Reviews Immunology
The immune response during acute HIV-1 infection: clues for vaccine development
McMichael, AJ; Borrow, P; Tomaras, GD; Goonetilleke, N; Haynes, BF
Nature Reviews Immunology, 10(1): 11-23.
10.1038/nri2674
CrossRef
Viral Immunology
Irreversible Loss of pDCs by Apoptosis During Early HIV Infection May Be a Critical Determinant of Immune Dysfunction
Meera, S; Madhuri, T; Manisha, G; Ramesh, P
Viral Immunology, 23(3): 241-249.
10.1089/vim.2009.0112
CrossRef
American Journal of Pathology
Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes
Engering, A; van Vliet, SJ; Hebeda, K; Jackson, DG; Prevo, R; Singh, SK; Geijtenbeek, TBH; van Krieken, H; van Kooyk, Y
American Journal of Pathology, 164(5): 1587-1595.

Molecular Pathogenesis of Virus Infections
The immune response to human immunodeficiency virus type 1 (HIV-1)
Turnbull, E; Borrow, P
Molecular Pathogenesis of Virus Infections, 64(): 23-89.

Journal of Immunology
Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction
Granelli-Piperno, A; Pritsker, A; Pack, M; Shimeliovich, I; Arrighi, JF; Park, CG; Trumpfheller, C; Piguet, V; Moran, TM; Steinman, RM
Journal of Immunology, 175(7): 4265-4273.

Journal of Virology
Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome
Diop, OM; Ploquin, MJY; Mortara, L; Faye, A; Jacquelin, B; Kunkel, D; Lebon, P; Butor, C; Hosmalin, A; Barre-Sinoussi, F; Mueller-Trutwin, MC
Journal of Virology, 82(): 5145-5152.
10.1128/JVI.02433-07
CrossRef
Journal of Virology
DC-SIGN Mediates Cell-Free Infection and Transmission of Human T-Cell Lymphotropic Virus Type 1 by Dendritic Cells
Jain, P; Manuel, SL; Khan, ZK; Ahuja, J; Quann, K; Wigdahl, B
Journal of Virology, 83(): 10908-10921.
10.1128/JVI.01054-09
CrossRef
Clinical Microbiology Reviews
Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection
de Repentigny, L; Lewandowski, D; Jolicoeur, P
Clinical Microbiology Reviews, 17(4): 729-+.
10.1128/CMR.17.4.729-759.2004
CrossRef
Immunologic Research
Dendritic cells and natural killer cells in the pathogenesis of HIV infection
Fortis, C; Poli, G
Immunologic Research, 33(1): 1-21.

Current Hiv Research
Sugar and spice: Viral envelope-DC-SIGN interactions in HIV pathogenesis
Su, SV; Gurney, KB; Lee, B
Current Hiv Research, 1(1): 87-99.

Journal of Infectious Diseases
HIV Infection Affects Blood Myeloid Dendritic Cells after Successful Therapy and despite Nonprogressing Clinical Disease
Fontaine, J; Coutlee, F; Tremblay, C; Routy, JP; Poudrier, J; Roger, M
Journal of Infectious Diseases, 199(7): 1007-1018.
10.1086/597278
CrossRef
Plos One
Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients
Lehmann, C; Lafferty, M; Garzino-Demo, A; Jung, N; Hartmann, P; Fatkenheuer, G; Wolf, JS; van Lunzen, J; Romerio, F
Plos One, 5(6): -.
ARTN e11110
CrossRef
Journal of Medical Primatology
Dichotomy between CD1a+ and CD83+ dendritic cells in lymph nodes during SIV infection of macaques
Soderlund, J; Nilsson, C; Lore, K; Castanos-Velez, E; Ekman, M; Heiden, T; Biberfeld, G; Andersson, J; Biberfeld, P
Journal of Medical Primatology, 33(1): 16-24.

Current Hiv Research
Humoral immunity in HIV-1 exposure: Cause or effect of HIV resistance?
Lopalco, L
Current Hiv Research, 2(2): 127-139.

Trends in Microbiology
Virus infection of dendritic cells: portal for host invasion and host defense
Rinaldo, CR; Piazza, P
Trends in Microbiology, 12(7): 337-345.
10.1016/j.tim.2004.05.003
CrossRef
Journal of Antimicrobial Chemotherapy
Role of therapeutic vaccines in the control of HIV-1
Kinloch-de Loes, S
Journal of Antimicrobial Chemotherapy, 53(4): 562-566.
10.1093/jac/dkh132
CrossRef
Cytometry, 4Th Edition: New Developments
Isolation and immunophenotyping of human and rhesus macaque dendritic cells
Lore, K
Cytometry, 4Th Edition: New Developments, 75(): 623-642.

Journal of Virology
Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells
Smed-Sorensen, A; Lore, K; Vasudevan, J; Louder, MK; Andersson, J; Mascola, JR; Spetz, AL; Koup, RA
Journal of Virology, 79(): 8861-8869.
10.1128/JVI.79.14.8861-8869.2005
CrossRef
Journal of Virology
Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection
Dong, CS; Janas, AM; Wang, JH; Olson, WJ; Wu, L
Journal of Virology, 81(): 11352-11362.
10.1128/JVI.01081-07
CrossRef
Retrovirology
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-I variants emerging during AIDS progression
Borggren, M; Repits, J; Kuylenstierna, C; Sterjovski, J; Churchill, MJ; Purcell, DFJ; Karlsson, A; Albert, J; Gorry, PR; Jansson, M
Retrovirology, 5(): -.
ARTN 28
CrossRef
Immunology
Effect of SIVmac infection on plasmacytoid and CD1c(+) myeloid dendritic cells in cynomolgus macaques
Malleret, B; Karlsson, I; Maneglier, B; Brochard, P; Delache, B; Andrieu, T; Muller-Trutwin, M; Beaumont, T; McCune, JM; Banchereau, J; Le Grand, R; Vaslin, B
Immunology, 124(2): 223-233.
10.1111/j.1365-2567.2007.02758.x
CrossRef
Apmis
The role of dendritic cells in the pathogenesis of HIV-1 infection
Lore, K; Larsson, M
Apmis, 111(): 776-788.

Immunology and Cell Biology
Vaccines that facilitate antigen entry into dendritic cells
Gamvrellis, A; Leong, D; Hanley, JC; Xiang, SD; Mottram, P; Plebanski, M
Immunology and Cell Biology, 82(5): 506-516.
10.1111/j.1440-1711.2004.01271.x
CrossRef
Journal of Infectious Diseases
Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects
Krathwohl, MD; Schacker, TW; Anderson, JL
Journal of Infectious Diseases, 193(4): 494-504.

Journal of Leukocyte Biology
HIV interactions with dendritic cells: has our focus been too narrow?
Donaghy, H; Wilkinson, J; Cunningham, AL
Journal of Leukocyte Biology, 80(5): 1001-1012.
10.1189/jlb.0306158
CrossRef
Blood
Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo
Choi, YK; Fallert, BA; Murphey-Corb, MA; Reinhart, TA
Blood, 101(5): 1684-1691.
10.1182/blood-2002-08-2653
CrossRef
Journal of Virology
Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs
Tsunetsugu-Yokota, Y; Morikawa, Y; Isogai, M; Kawana-Tachikawa, A; Odawara, T; Nakamura, T; Grassi, F; Autran, B; Iwamoto, A
Journal of Virology, 77(): 10250-10259.
10.1128/JVL.77.19.10250-10259.2003
CrossRef
Journal of Virology
The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11b(Hi) dendritic cells
Poudrier, J; Weng, XD; Kay, DG; Hanna, Z; Jolicoeur, P
Journal of Virology, 77(): 11733-11744.
10.1128/JVI.77.21.11733-11744.2003
CrossRef
Springer Seminars in Immunopathology
HIV-1 and the hijacking of dendritic cells: a tug of war
Larsson, M
Springer Seminars in Immunopathology, 26(3): 309-328.
10.1007/s00281-004-0178-y
CrossRef
Journal of Dermatology
A case of symptomatic primary HIV infection
Kobayashi, S; Segawa, S; Kawashima, M; Itoda, I; Shima, T; Imai, M
Journal of Dermatology, 32(2): 137-142.

Immunological Reviews
Immune privilege and HIV-1 persistence in the CNS
Persidsky, Y; Poluektova, L
Immunological Reviews, 213(): 180-194.

Journal of Virology
Infection of CD127(+) (Interleukin-7 receptor(+)) CD4(+) cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection
Zaunders, JJ; Ip, S; Munier, ML; Kaufmann, DE; Suzuki, K; Brereton, C; Sasson, SC; Seddiki, N; Koelsch, K; Landay, A; Grey, P; Finlayson, R; Kaldor, J; Rosenberg, ES; Walker, BD; Fazekas de St Groth, B; Cooper, DA; Kelleher, AD
Journal of Virology, 80(): 10162-10172.
10.1128/JVI.00249-06
CrossRef
Journal of Virology
CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1
Wang, JH; Janas, AM; Olson, WJ; KewalRamani, VN; Wu, L
Journal of Virology, 81(5): 2497-2507.
10.1128/JVI.01970-06
CrossRef
Journal of Leukocyte Biology
Role of gp120 in dendritic cell dysfunction in HIV infection
Chougnet, C; Gessani, S
Journal of Leukocyte Biology, 80(5): 994-1000.
10.1189/jlb.0306135
CrossRef
Trends in Immunology
STI and beyond: the prospects of boosting anti-HIV immune responses
Allen, TM; Kelleher, AD; Zaunders, J; Walker, BD
Trends in Immunology, 23(9): 456-460.
PII S1471-4906(02)02297-4
CrossRef
Blood
Failure of HIV-exposed CD4(+) T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions
Zhang, R; Lifson, JD; Chougnet, C
Blood, 107(5): 1989-1995.
10.1182/blood-2005-07-2731
CrossRef
Journal of Immunology
Altered CD4(+) T cell phenotype and function determine the susceptibility to mucosal candidiasis in Transgenic mice expressing HIV-1
Lewandowski, D; Marquis, M; Aumont, F; Lussier-Morin, AC; Raymond, M; Senechal, S; Hanna, Z; Jolicoeur, P; Repentigny, L
Journal of Immunology, 177(1): 479-491.

American Journal of Pathology
Compartmentalization of Immune Responses in Human Tuberculosis Few CD8 + Effector T Cells but Elevated Levels of FbxP3 + Regulatory T Cells in the Granulomatous Lesions
Rahman, S; Gudetta, B; Fink, J; Granath, A; Ashenafi, S; Aseffa, A; Derbew, M; Svensson, M; Andersson, J; Brighenti, SG
American Journal of Pathology, 174(6): 2211-2224.
10.2353/ajpath.2009.080941
CrossRef
Immunology Letters
Immune impairment thresholds in HIV infection
Iwami, S; Nakaoka, S; Takeuchi, Y; Miura, Y; Miura, T
Immunology Letters, 123(2): 149-154.
10.1016/j.imlet.2009.03.007
CrossRef
Journal of Experimental Medicine
Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue
Hu, QX; Frank, I; Williams, V; Santos, JJ; Watts, P; Griffin, GE; Moore, JR; Pope, M; Shattock, RJ
Journal of Experimental Medicine, 199(8): 1065-1075.
10.1084/jem.20022212
CrossRef
International Immunology
HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro
Muthumani, K; Hwang, DS; Choo, AY; Mayilvahanan, S; Dayes, NS; Thieu, KP; Weiner, DB
International Immunology, 17(2): 103-116.
10.1093/intimm/dxh190
CrossRef
Journal of Leukocyte Biology
Type I interferon production in HIV-infected patients
Hosmalin, A; Lebon, P
Journal of Leukocyte Biology, 80(5): 984-993.
10.1189/jlb.0306154
CrossRef
Current Hiv Research
Multiple Roles for Chemokines in the Pathogenesis of SIV Infection
Reinhart, TA; Qin, SL; Sui, YJ
Current Hiv Research, 7(1): 73-82.

Journal of Theoretical Biology
Immune impairment in HIV infection: Existence of risky and immunodeficiency thresholds
Iwami, S; Miura, T; Nakaoka, S; Takeuchi, Y
Journal of Theoretical Biology, 260(4): 490-501.
10.1016/j.jtbi.2009.06.023
CrossRef
Journal of Pathology
Productive infection of dendritic cells by simian immunodeficiency virus in macaque intestinal tissues
Choi, YK; Whelton, KM; Mlechick, B; Murphey-Corb, MA; Reinhart, TA
Journal of Pathology, 201(4): 616-628.
10.1002/path.1482
CrossRef
AIDS Research and Human Retroviruses
Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: A possible in vitro model for postexposure prophylaxis of sexual HIV transmission
Van Herrewege, Y; Penne, L; Vereecken, C; Fransen, K; Van der Groen, G; Kestens, L; Balzarini, J; Vanham, G
AIDS Research and Human Retroviruses, 18(): 1091-1102.

Biofutur
Structured treatment interruption and beyond
Allen, TM; Kelleher, AD; Zaunders, J; Walker, BD
Biofutur, (): 52-58.

Journal of Immunology
Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function
Malaspina, A; Moir, S; Kottilil, S; Hallahan, CW; Ehler, LA; Liu, SY; Planta, MA; Chun, TW; Fauci, AS
Journal of Immunology, 170(): 5965-5972.

Trends in Immunology
Chemokine induction by HIV-1: recruitment to the cause
Reinhart, TA
Trends in Immunology, 24(7): 351-353.
10.1016/S1471-4906(03)00163-7
CrossRef
AIDS
Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis
Tasca, S; Tambussi, G; Nozza, S; Capiluppi, B; Zocchi, MR; Soldini, L; Veglia, F; Poli, G; Lazzarin, A; Fortis, C
AIDS, 17(): 2291-2298.
10.1097/01.aids.0000096851.36052.a4
CrossRef
Proceedings of the National Academy of Sciences of the United States of America
HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype
Fiorentini, S; Riboldi, E; Facchetti, F; Avolio, M; Fabbri, M; Tosti, G; Becker, PD; Guzman, CA; Sozzani, S; Caruso, A
Proceedings of the National Academy of Sciences of the United States of America, 105(): 3867-3872.
10.1073/pnas.0800370105
CrossRef
Immunological Reviews
Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections
Ha, SJ; West, EE; Araki, K; Smith, KA; Ahmed, R
Immunological Reviews, 223(): 317-333.

Blood
Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression
Malleret, B; Maneglier, B; Karlsson, I; Lebon, P; Nascimbeni, M; Perie, L; Brochard, P; Delache, B; Calvo, J; Andrieu, T; Spreux-Varoquaux, O; Hosmalin, A; Le Grand, R; Vaslin, B
Blood, 112(): 4598-4608.
10.1182/blood-2008-06-162651
CrossRef
Biochemical and Biophysical Research Communications
Induction and regulation of CD8+cytolytic T cells in human tuberculosis and HIV infection
Brighenti, S; Andersson, J
Biochemical and Biophysical Research Communications, 396(1): 50-57.
10.1016/j.bbrc.2010.02.141
CrossRef
Nature Reviews Immunology
Dendritic-cell interactions with HIV: infection and viral dissemination
Wu, L; KewalRamani, VN
Nature Reviews Immunology, 6(): 859-868.
10.1038/nri1960
CrossRef
Nature Immunology
Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication
Hodges, A; Sharrocks, K; Edelmann, M; Baban, D; Moris, A; Schwartz, O; Drakesmith, H; Davies, K; Kessler, B; McMichael, A; Simmons, A
Nature Immunology, 8(6): 569-577.
10.1038/ni1470
CrossRef
Plos Pathogens
Major Depletion of Plasmacytoid Dendritic Cells in HIV-2 Infection, an Attenuated Form of HIV Disease
Cavaleiro, R; Baptista, AP; Soares, RS; Tendeiro, R; Foxall, RB; Gomes, P; Victorino, RMM; Sousa, AE
Plos Pathogens, 5(): -.
ARTN e1000667
CrossRef
AIDS
Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection
Nilsson, J; Kinloch-de-Loes, S; Granath, A; Sönnerborg, A; Goh, L; Andersson, J
AIDS, 21(5): 565-574.
10.1097/QAD.0b013e3280117204
PDF (294) | CrossRef
AIDS
Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection
Gloster, SE; Newton, P; Cornforth, D; Lifson, JD; Williams, I; Shaw, GM; Borrow, P
AIDS, 18(5): 749-755.

PDF (108)
Current Opinion in Infectious Diseases
Antigen presentation and the role of dendritic cells in HIV
Donaghy, H; Stebbing, J; Patterson, S
Current Opinion in Infectious Diseases, 17(1): 1-6.

PDF (97)
JAIDS Journal of Acquired Immune Deficiency Syndromes
Plasmacytoid and Myeloid Dendritic Cells With a Partial Activation Phenotype Accumulate in Lymphoid Tissue During Asymptomatic Chronic HIV-1 Infection
Dillon, SM; Robertson, KB; Pan, SC; Mawhinney, S; Meditz, AL; Folkvord, JM; Connick, E; McCarter, MD; Wilson, CC
JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(1): 1-12.
10.1097/QAI.0b013e3181664b60
PDF (659) | CrossRef
Journal of Pediatric Hematology/Oncology
Natural Killer Deficiency: A Minor or Major Factor in the Manifestation of Hemophagocytic Lymphohistiocytosis?
Schneider, EM; Lorenz, I; Walther, P; Janka-Schaub, GE
Journal of Pediatric Hematology/Oncology, 25(9): 680-683.

PDF (301)
Back to Top | Article Outline
Keywords:

HIV-1; dendritic cell; cytokines; co-stimulatory molecule; DC-SIGN; lymphoid tissue; primary HIV-1 infection

© 2002 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.